PP2A‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells

OV Denisova, J Merisaari, R Huhtaniemi… - Molecular …, 2023 - Wiley Online Library
Mitochondrial glycolysis and hyperactivity of the phosphatidylinositol 3‐kinase–protein
kinase B (AKT) pathway are hallmarks of malignant brain tumors. However, kinase inhibitors …

[HTML][HTML] Role of protein phosphatases PP1, PP2A, PP4 and Cdc14 in the DNA damage response

F Ramos, MT Villoria, E Alonso-Rodríguez… - Cell stress, 2019 - ncbi.nlm.nih.gov
Maintenance of genome integrity is fundamental for cellular physiology. Our hereditary
information encoded in the DNA is intrinsically susceptible to suffer variations, mostly due to …

GREM1/PPP2R3A expression in heterogeneous fibroblasts initiates pulmonary fibrosis

X Shi, J Wang, X Zhang, S Yang, W Luo, S Wang… - Cell & Bioscience, 2022 - Springer
Background Fibroblasts have important roles in the synthesis and remodeling of
extracellular matrix (ECM) proteins during pulmonary fibrosis. However, the spatiotemporal …

Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: A potential therapeutic target?

IS Elgenaidi, JP Spiers - Pharmacology & therapeutics, 2019 - Elsevier
Phosphoprotein phosphatases are of growing interest in the pathophysiology of many
diseases and are often the neglected partner of protein kinases. One family member, PP2A …

[HTML][HTML] Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma

R Tohmé, S Izadmehr, S Gandhe, G Tabaro… - JCI insight, 2019 - ncbi.nlm.nih.gov
Although tyrosine kinase inhibitors (TKIs) have demonstrated significant efficacy in
advanced lung adenocarcinoma (LUAD) patients with pathogenic alterations in EGFR, most …

Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity

T Risom, X Wang, J Liang, X Zhang… - The Journal of …, 2020 - Am Soc Clin Investig
The c-MYC (MYC) oncoprotein is often overexpressed in human breast cancer; however, its
role in driving disease phenotypes is poorly understood. Here, we investigate the role of …

Retracted: Long non‐coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA‐21

J Zhao, C Zhang, Z Gao, H Wu, R Gu… - Journal of cellular …, 2018 - Wiley Online Library
Osteosarcoma is the most common malignant bone tumor in children and adolescents with
high rate of incidence, high frequency of recurrence, and high degree of metastasis. This …

The sustained induction of c-MYC drives nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells

E Parasido, GS Avetian, A Naeem, G Graham… - Molecular Cancer …, 2019 - AACR
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with limited and,
very often, ineffective medical and surgical therapeutic options. The treatment of patients …

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

CC Farrington, E Yuan, S Mazhar, S Izadmehr… - Journal of Biological …, 2020 - ASBMB
The tumor suppressor protein phosphatase 2A (PP2A) is a serine/threonine phosphatase
whose activity is inhibited in most human cancers. One of the best-characterized PP2A …

Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'

G Taleski, E Sontag - FEBS letters, 2018 - Wiley Online Library
The neuronal microtubule‐associated protein tau serves a critical role in regulating axonal
microtubule dynamics to support neuronal and synaptic functions. Furthermore, it contributes …